Organigram Q4 Revenue Increases 22% to $24.9 Million

Organigram Reports Fourth Quarter Fiscal 2021 Results Continued growth in net revenue and increased market share Achieved a 7% share of market in the recreational cannabis market in Q4, up from 5.4% in Q3 2021, positioning Organigram as the #4 licensed producer and the momentum continues with a 7.9% share of market as of October.1 […]